Why Exercise Matters for Lean Mass During Weight Loss

Diet-only weight loss may be harder on lean mass for some people

A calorie deficit can reduce fat mass and lean mass at the same time. The useful question is not whether that happens—it often does—but who is most likely to lose lean tissue and what changes the odds. The best direct evidence here points to exercise. In a 2025 randomized weight-loss study, baseline insulin sensitivity predicted lean-mass retention during dieting alone, but did not predict it when participants added aerobic or resistance exercise.

That finding does not mean insulin sensitivity is destiny, nor does it prove that exercise erases every consequence of poor metabolic health. It does give people pursuing fat loss a practical priority: avoid treating training as decorative while you diet. A scale cannot tell whether the pounds lost came mostly from fat or partly from tissue you would rather keep.

Insulin sensitivity predicted lean-mass loss only in the diet-only group

The central study, Bartholomew et al. (2025), enrolled sedentary, normal-glucose-tolerant premenopausal women with overweight. Researchers randomized participants to calorie restriction alone, calorie restriction plus aerobic training, or calorie restriction plus resistance training. They measured insulin sensitivity before weight loss with an intravenous glucose tolerance test and measured total and appendicular lean mass with DXA.

Women with higher baseline insulin sensitivity retained more total lean mass and appendicular lean mass during diet-only weight loss. In the aerobic- and resistance-training groups, baseline insulin sensitivity no longer predicted lean-mass change. The practical implication is narrower, and more useful, than a claim that one blood marker rules body composition: in this population, exercise changed the relationship between metabolic starting point and lean-mass loss.

The study design earns more weight than a simple observational association because exercise assignment was randomized. Still, the population sets a firm boundary. These were younger premenopausal women with normal glucose tolerance, not men, older adults, people with type 2 diabetes, people with sarcopenia, or patients using anti-obesity drugs. A result in a tightly defined group should guide a hypothesis for other groups, not impersonate proof for all of them.

An earlier study supports the vulnerability idea, with less context

Bartholomew et al. (2024) found the same broad pattern: better baseline insulin sensitivity was associated with less loss of total and appendicular lean mass during intentional weight loss. That supports the idea that metabolic health at the start of a diet may affect how much lean tissue a person loses.

Association is the operative word. The earlier paper did not provide the same randomized exercise comparison as the 2025 trial, so it cannot establish that exercise overrides the relationship. Program design, participant characteristics, and other correlated behaviors could influence an association of this kind. Taken together, the two papers support a specific conclusion: poorer insulin sensitivity may identify greater vulnerability during weight loss without exercise in some adults. They do not establish a universal screening rule.

Exercise has broader support than any single biomarker

Other intervention research strengthens the case for including exercise when weight loss is the goal. A 2023 systematic review and network meta-analysis of randomized trials in adults near retirement age assessed nutrition and exercise strategies for body composition in people with overweight or obesity. Its findings support exercise, especially programs that include resistance work, as part of preserving body composition during weight loss.

A randomized trial in older adults with obesity likewise found that weight loss and exercise affected insulin sensitivity, body composition, cardiorespiratory fitness, and muscle strength differently. This does not replicate the 2025 insulin-sensitivity interaction: the participants and study question differed. It does show why "lose weight" is an incomplete prescription. Exercise modality can alter what happens to function and body composition while body weight falls.

Older adults with obesity are also not interchangeable with sedentary premenopausal women with normal glucose tolerance. Yet the studies converge on the most actionable point in this evidence: exercise belongs in a high-quality weight-loss plan, particularly when preserving lean tissue and physical capacity matter.

FGF19 is an interesting clue, not a muscle-preservation tool

The proposed biological explanation is more tentative. In Wean et al. (2024), 176 adults with obesity completed a 3- to 4-month very-low-energy diet providing 800 kcal per day. Participants had a mean age of 50 years, and 56% were women. The study examined whether circulating fibroblast growth factor 19 (FGF19), a gut-derived hormone, related to lean-mass outcomes after rapid weight loss.

After adjustment for age, sex, and baseline percent lean mass, baseline FGF19 significantly predicted post-intervention percent lean mass. That is a body-composition association, not proof that FGF19 causes muscle loss or preservation. More importantly for anyone tempted to shop for a biomarker shortcut, prediction of the change in percent lean mass did not reach conventional statistical significance: the reported p values were 0.067 for baseline FGF19 and 0.063 for post-diet FGF19.

The study also did not isolate a pure diet-only exposure; participants were advised to do 40 minutes per day of mild-to-moderate activity. Its rapid-loss setting may differ biologically from a slower, ordinary fat-loss phase. FGF19 therefore remains a plausible research lead in gut-muscle communication, not a validated test, target, or supplement strategy. Biology is often more interesting before it becomes useful.

Lean mass is useful, but it is not the whole outcome

These studies primarily use lean mass or related body-composition measures. Lean mass is valuable, especially during energy restriction, but it does not directly measure muscle protein turnover, contractile tissue quality, strength, or long-term function. A person can care about a DXA result and still care more about whether they remain strong enough to climb stairs, carry groceries, and train consistently.

Measurement method adds another layer of uncertainty. A 2023 study comparing 3D optical imaging with DXA found that advancing 3D optical imaging could track body-composition change with comparable accuracy and sensitivity across intervention studies. That may make monitoring more accessible, but it does not convert any scan into a direct readout of muscle quality. Hydration, tissue compartments, and the limits of the measurement all still matter when interpreting changes in lean mass.

What to do with this evidence

If your goal is fat loss while retaining as much lean tissue as possible, include structured exercise rather than relying on calorie restriction alone. Resistance training has the most obvious connection to maintaining muscle, while the 2025 trial indicates that both aerobic and resistance training changed the insulin-sensitivity pattern seen with diet alone. The best program is one you can perform consistently and safely, with enough recovery to tolerate the calorie deficit.

• Use body weight as one outcome, not the entire scorecard.
• Include structured aerobic or resistance exercise during a planned calorie deficit when medically appropriate.
• Track function and training performance alongside body composition when possible.
• Treat FGF19 testing, if available, as research information rather than a decision tool.

The evidence supports exercise as the practical lever. It supports baseline insulin sensitivity as a possible risk marker in specific settings. It does not support biomarker-driven muscle-preservation claims.

Future trials need to test the insulin-sensitivity finding in broader populations and determine whether FGF19 predicts lean-mass change independently across slower and faster weight-loss programs. Until then, the defensible advice is pleasantly unglamorous: build exercise into the diet phase, and do not expect a hormone measurement to do the lifting for you.